CD44 and neoplasm: In Kaplan–Meier survival analyses, the patients with increased CD44+/CD24− and ALDH1+ tumour cell populations had a significantly shorter DFS times than the remaining patients (P=0.043 and 0.041, respectively) (Figures 4A and B).